If you missed it on cannasos.com you have to read up on the DEA green-lighting a clinical trial of smoked MJ for the treatment of post-traumatic stress disorder (PTSD) in American military veterans. This marks the first time approved smoking marijuana as legitimate medical research by the U.S. Drug Enforcement Administration.
The DEA green-lit a clinical trial of smoked marijuana for the treatment of post-traumatic stress disorder (PTSD) in American military veterans, a spokesperson for the government agency confirmed to CannaSOS. While other trials have studied the medical benefits of marijuana and cannabis extracts like cannabidiol, this is the first time regulators have allowed testing of the marijuana plant itself for the purpose of developing it into a legal medical drug.
The Multidisciplinary Association for Psychedelic Studies (MAPS), an organization researching legal uses for marijuana and other mind-altering drugs, is conducting the trial, which is funded by a $2.2 million grant from Colorado’s state health department. MAPS had worked for more than five years to obtain clearance from regulators to use pot in the trial; while it received the OK from the U.S. Food and Drug Administration in 2011 and from the U.S. Public Health Service in 2014, it still had to wait for the DEA’s approval in order to proceed.
Since then, however, the DEA has apparently had a change of heart, indicating earlier this month that it is considering whether to reclassify marijuana from its current category—the same one as heroin and LSD—into a lower one alongside less dangerous drugs. So far, DEA has not rejected any research studies involving marijuana products that met FDA standards, the agency’s spokesperson added.